Red blood cell transfusions at 21 days of age or older in previously transfusion-naive very preterm infants: association with neonatal outcomes
dc.contributor.author | Keir, A. | |
dc.contributor.author | Aziz, K. | |
dc.contributor.author | McMillan, D. | |
dc.contributor.author | Monterrosa, L. | |
dc.contributor.author | Ojah, C. | |
dc.contributor.author | Lee, S. | |
dc.contributor.author | Shah, P. | |
dc.date.issued | 2015 | |
dc.description.abstract | This study aims to assess the association of red blood cell (RBC) transfusion in a cohort of preterm infants with mortality, retinopathy of prematurity (ROP), and chronic lung disease (CLD) transfused at ≥21 days of life.This retrospective cohort study included infants born at <30 weeks' gestation who survived ≥21 days, had not received any RBC transfusions before reaching 21 days of age, and were admitted to participating units in the Canadian neonatal network (2003-2009).Out of the 3,799 eligible infants, 3,309 infants did not receive RBC transfusion at ≥21 days of age, whereas 490 received transfusion at ≥21 days of age. Infants who did not receive RBC transfusion/s at ≥21 days of age had higher birth weight (p<0.01) and higher gestational age at the time of birth (p<0.01) as compared with those who received transfusion/s at ≥21 days of age. Receipt of RBC transfusion/s at ≥21 days of age was not associated with mortality (adjusted odds ratio [AOR] 1.20; 95% confidence interval [CI] 0.33-4.34) or severe ROP (AOR 1.02; 95% CI 0.59-1.77) but was associated with increased odds of CLD (AOR 1.78; 95% CI 1.43-2.22).RBC transfusion/s at ≥21 days of age in previously transfusion-naive preterm infants was associated with increased odds of CLD but not with ROP or mortality. | |
dc.description.statementofresponsibility | Amy Keir, Khalid Aziz, Douglas McMillan, Luis Monterrosa, Cecil Ojah, Shoo Lee, Prakesh S. Shah, on behalf of the Canadian Neonatal Network | |
dc.identifier.citation | American Journal of Perinatology, 2015; 32(12):1139-1144 | |
dc.identifier.doi | 10.1055/s-0035-1549295 | |
dc.identifier.issn | 0735-1631 | |
dc.identifier.issn | 1098-8785 | |
dc.identifier.orcid | Keir, A. [0000-0003-1692-5676] | |
dc.identifier.uri | http://hdl.handle.net/2440/102876 | |
dc.language.iso | en | |
dc.publisher | Thieme | |
dc.rights | Copyright status unknown | |
dc.source.uri | https://doi.org/10.1055/s-0035-1549295 | |
dc.subject | Infant; newborn; premature; red blood cell transfusion; adverse affects | |
dc.title | Red blood cell transfusions at 21 days of age or older in previously transfusion-naive very preterm infants: association with neonatal outcomes | |
dc.type | Journal article | |
pubs.publication-status | Published |